Palatability of Oral Rehydration Solutions

Study Overview
=================
Brief Summary
-----------------
The primary objective of this study is to compare the mean taste scores for three fruit flavored oral rehydration solutions in children aged 5-10 years old. The secondary objective is to compare the proportions of children who indicate a taste preference for one of the solutions.

Detailed Description
-----------------
In Canada, acute gastroenteritis remains a major cause of morbidity and hospitalizations. This, in large part, is due to an inability to realize the full benefits of oral rehydration therapy. Because oral rehydration solutions have a salty taste, many mild to moderate dehydrated children refuse to drink them. This has resulted in pediatricians recommending inappropriate solutions and the unnecessary administration of intravenous fluids. Although two meta-analyses have concluded that rice-based ORS (Enfalyte) is as or more effective than traditional ORS in reducing stool output, the palatability of different oral rehydration solutions have never been evaluated. This will be the first prospective trial comparing the palatability of the most commonly recommended oral rehydration solutions, Pedialyte and Enfalyte with a newer solution, Pediatric Electrolyte. Both Pedialyte and Pediatric Electrolyte contain sucralose, dextrose, and fructose while Enfalyte contains rice syrup solids. Although the latter is as, or more effective than Pedialyte in reducing stool output, palatability may limit its use. Taste is important as children with gastroenteritis are frequently nauseated and may refuse to drink or vomit when consuming less palatable solutions. We hypothesize that, compared to children who receive a rice-based ORS (Enfalyte), those who receive a sucralose ORS (Pediatric Electrolyte or Pedialyte) will report a higher mean taste score, will prefer to drink the sucralose sweetened ORS if they had to consume a larger volume, and are more likely to drink the entire volume they are provided.

Official Title
-----------------
Palatability of Oral Rehydration Solutions

Conditions
-----------------
Gastroenteritis

Intervention / Treatment
-----------------
* Drug: Enfalyte
* Drug: Pediatric Electrolyte
* Drug: Pedialyte


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Children 5-10 years of age evaluated in The Hospital for Sick Children's emergency department Exclusion Criteria: Children with diarrhea, a vomiting or diarrhea episode within 24 hours, head trauma, abdominal pain, upper respiratory symptoms, or nil per os status Patients with gastrointestinal symptoms

Ages Eligible for Study
-----------------
Minimum Age: 5 Years
Maximum Age: 10 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Other
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Quadruple


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Active Comparator: 1<br> | Drug: Enfalyte<br>* Each patient will receive one 250 ml dose.<br>|
| Experimental: 2<br> | Drug: Pediatric Electrolyte<br>* Each patient will receive one 250 ml dose.<br>|
| Experimental: 3<br> | Drug: Pedialyte<br>* Each patient will receive one 250 ml dose.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Mean taste scores for Pedialyte, Pediatric Electrolyte, and Enfalyte. |  | Immediately following consumption of each solution. | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Proportions of children who indicate a taste preference for one of the solutions. |  | Immediately following consumption of each solution. | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Gastroenteritis, Pediatrics, Rehydration therapy